Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
232
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

270
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
270
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

239
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
239
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

151
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
151

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diversion of Arginine's dietary metabolic fate in proteinuric kidney disease.

Research square·2026
Same author

The importance of clinical context in evaluating algorithmic fairness: insights from a medication adherence prediction algorithm.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.

Fundamental & clinical pharmacology·2026
Same author

Burden of Residual Angina Among Older Adults With Ischemic Heart Disease in the United States: Findings From the RESILIENT Trial.

Circulation. Population health and outcomes·2026
Same author

Epidemiology of cardiovascular-kidney-metabolic syndrome.

Nature reviews. Nephrology·2026
Same journal

Comparative Evaluation of Pretrained Large Language Models for Suicide Risk Prediction from Clinical Notes in U.S. Veterans.

medRxiv : the preprint server for health sciences·2026
Same journal

Nocturnal Respiratory Rate and Variability Predict Long-term Mortality in Stable Outpatients with Cardiovascular Disease.

medRxiv : the preprint server for health sciences·2026
Same journal

MOSAIC: Methylation-Oriented Site Analysis and Information Classifier for Robust Epigenomic Classification of Acute Leukemia in Clinical Cohorts with Variable Tumor Purity.

medRxiv : the preprint server for health sciences·2026
Same journal

Risk beliefs, intensive digital information and demand for a new preventative health product in public clinics: Evidence from an experiment in Zimbabwe.

medRxiv : the preprint server for health sciences·2026
Same journal

Development of an automated, imaging-based preoperative screening model for early identification of malnutrition in an abdominal surgery cohort.

medRxiv : the preprint server for health sciences·2026
Same journal

A Pilot Project Leveraging Large Language Models for Automated Screening and Variable Extraction in Observational Studies.

medRxiv : the preprint server for health sciences·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K

Measuring Adherence to Multiple Medications Using Guideline-Directed Medical Therapy as a Model.

Eli Reynolds1, Xiyue Li2, Amrita Mukhopadhyay2,3

  • 1Department of Internal Medicine, New York University Langone Health.

Medrxiv : the Preprint Server for Health Sciences
|December 18, 2025
PubMed
Summary
This summary is machine-generated.

Measuring medication adherence in heart failure patients using proportion of days covered (PDC) shows wide variability. The chosen PDC method significantly impacts adherence assessment and clinical outcome interpretation for guideline-directed-medical therapy (GDMT).

Keywords:
GDMTadherenceheart failuremedication adherencemultiple medicationsproportion of days coveredproportion of days covered (PDC)

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.2K

Related Experiment Videos

Last Updated: Jan 8, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.2K

Area of Science:

  • Cardiology
  • Pharmacoeconomics
  • Health Services Research

Background:

  • Heart failure (HF) management necessitates complex medication regimens, termed guideline-directed-medical therapy (GDMT).
  • Assessing adherence to multiple HF medications is challenging due to the lack of a gold standard.
  • Proportion of days covered (PDC) is a common metric for medication adherence.

Purpose of the Study:

  • To compare seven different Proportion of Days Covered (PDC) measures for assessing adherence to multiple guideline-directed-medical therapy (GDMT) medications in heart failure (HF) patients.
  • To evaluate the association between these various PDC adherence measures and clinical outcomes.

Main Methods:

  • A retrospective cohort study included 34,603 heart failure patients who filled GDMT prescriptions between April 2021 and July 2022.
  • Seven PDC-based adherence measures were derived from electronic health record and pharmacy data.
  • Clinical outcomes included emergency department visits, hospitalizations, and death.

Main Results:

  • A wide range of adherence was observed across the seven PDC measures, from 54% with the strictest ('each') to 73% with the least restrictive ('at least one') measure.
  • Adherence variability increased with a higher number of GDMT medications.
  • Higher PDC across all measures was associated with an increased number of emergency department visits, hospitalizations, and death.

Conclusions:

  • The choice of Proportion of Days Covered (PDC) measure significantly impacts the assessment of medication adherence in heart failure patients on guideline-directed-medical therapy (GDMT).
  • This variability has substantial implications for policy, clinical practice, and intervention strategies.
  • Further research is needed to establish a standardized and validated approach for measuring multi-medication adherence.